Rite Aid Addresses Cyberattack: 2.2 Million Customers’ Data Breached
Drug Topics
JULY 17, 2024
The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.
Drug Topics
JULY 17, 2024
The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.
STAT
JULY 17, 2024
Vaccination lowers the chance of developing long Covid, according to a large new study that also found that the risk of serious complications has diminished but not disappeared as new coronavirus variants emerged. The study, published Wednesday in the New England Journal of Medicine , compared the health records of more than 440,000 Veterans Affairs patients who were infected with Covid-19 with records of more than 4 million uninfected people.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 17, 2024
“If people think COVID is no big deal and decide to forgo vaccinations, they’re essentially doubling their risk of developing long COVID,” wrote investigators.
STAT
JULY 17, 2024
Around the world, patients suddenly can’t find enough of the insulins made by companies they have long relied on to do so. In the U.S., Novo Nordisk’s recent decision to discontinue a product has left patients with fewer options. At the same time, patients are encountering shortages of other products from Novo and Eli Lilly. For months, pharmacies have been running out of vials of certain insulins that patients use to fill the pumps they wear on their body.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JULY 17, 2024
Healthcare costs are set to rise between 7% and 8% in 2025, according to a new report from PwC. | Healthcare costs are set to rise between 7% and 8% in 2025, according to a new report from PwC.
STAT
JULY 17, 2024
As a hematologist-oncologist in Miami, Mikkael Sekeres always hopes his patients will find a perfect match for the bone marrow transplant they need to save their lives — but he doesn’t expect it. Most of his patients are Latino or African American, and rates of perfect matches are much lower for racial or ethnic minorities. That gloomy picture could soon change.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JULY 17, 2024
Taking the oral examination is the final step in becoming a board-certified obstetrician and gynecologist (OB-GYN). It is a challenge in the best of circumstances. But instead of worrying about how to respond to questions about the management of uterine cancers or peripartum hemorrhage, test candidates are worried about the legal risks of taking this exam, which must be done in Dallas, home of the American Board of Obstetrics and Gynecology (ABOG).
Pharmacy Times
JULY 17, 2024
A patient with severe and recurrent pemphigus vulgaris achieved lasting remission with a novel intravenous immunoglobulin preparation that had the added benefit of reducing treatment-related side effects.
STAT
JULY 17, 2024
Wall Street’s reaction was swift Wednesday after Elevance Health said that the amount of care its Medicaid members are getting is outpacing what states are paying the insurer to treat those members. Elevance’s stock tumbled almost 6% even though the company reported earnings that beat Wall Street’s estimates, and a slightly higher operating gain in the second quarter of 2024 compared with the prior-year period.
Fierce Healthcare
JULY 17, 2024
Grocery delivery company Instacart continues to expand its reach in healthcare and has notched a major health system partnership. | The first program to launch integrates Instacart Health tools into Northwell’s Center for Maternal Health Maternal Outcomes and Morbidity Collaborative (MOMS) so that moms-to-be who are food insecure have improved access to fresh and nutritious food.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Topics
JULY 17, 2024
Patients with childhood type 1 diabetes were more likely to develop substance use disorders, mood disorders, anxiety disorders, and behavioral syndromes.
STAT
JULY 17, 2024
Gilead Sciences’ chief medical officer will leave the company early next year as the drugmaker struggles to find new areas of growth beyond its core portfolio of HIV medicines. Merdad Parsey, who joined Gilead in 2019, will stay in his post until the first quarter of next year as the company looks for a successor, Gilead said in a press release Wednesday.
Pharmacy Times
JULY 17, 2024
Radiotherapy may have applications beyond symptomatic relief when used in combination with immunotherapy.
STAT
JULY 17, 2024
For scientists and medical professionals well versed in the safety and effectiveness of vaccines, it is often too easy to write off the concerns of people who fear them, or feel they have been injured by them. But vaccine expert Kizzmekia S. Corbett-Helaire argues that professionals should be more empathetic when it comes to listening to these concerns, and that understanding them may help developers make better vaccines.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
JULY 17, 2024
Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer (mHSPC). | Bayer has claimed a second pivotal trial win for its blockbuster-to-be androgen receptor inhibitor Nubeqa, looking to reach the entire space of metastatic hormone-sensitive prostate cancer.
STAT
JULY 17, 2024
LONDON — Roche on Wednesday reported positive early data from another of the obesity drug candidates that it picked up through an acquisition late last year, bolstering the case it could become a player in the competitive weight-loss medicine field. The company said its once-daily pill, called CT-996, led to a placebo-adjusted average weight loss of 6.1% after four weeks in patients with obesity who did not have diabetes.
Pharmacy Times
JULY 17, 2024
Many ways exist to best serve communities and the bottom line beyond vaccine ordering and increased staffing.
STAT
JULY 17, 2024
Faced with widespread skepticism about the value of digital therapies, Swing Therapeutics in early 2022 set out to make the strongest case possible for its app-based treatment for fibromyalgia. In a year-long pivotal trial for Swing’s treatment, called Stanza, participants were told they were receiving one of two potentially effective treatments for fibromyalgia.
Fierce Healthcare
JULY 17, 2024
Elevance Health beat the Street on both profit and revenue in the second quarter, according to its earnings report released on Wednesday.
STAT
JULY 17, 2024
Federal guidance restricting hospital websites’ use of third-party trackers along with the proliferation of direct-to-consumer health services is spawning a new crop of health tech startups promising to help beleaguered providers stay on the right side of the law. Among them is San Francisco startup Freshpaint, which on Wednesday announced a $30 million Series B round to sell its privacy platform to providers, pharmacies, insurers.
pharmaphorum
JULY 17, 2024
Get insights into Dr James Burt's leadership as CEO of Pharmanovia through a 12-question interview that covers his background, achievements, and vision for the company.
STAT
JULY 17, 2024
Cassava Sciences is imploding — and as it crumbles, a dark, ugly corner of the Alzheimer’s disease world is being exposed and will hopefully get cleaned up. Remi Barbier, Cassava’s longtime CEO, has resigned and is also leaving the board, the company announced Wednesday. Lindsay Burns, Cassava’s senior vice president of neuroscience, is gone, too.
European Pharmaceutical Review
JULY 17, 2024
European Pharmacopoeia has confirmed it will remove the rabbit pyrogen test (RPT) from its monographs. This milestone decision was made during the Ph. Eur.’s 179th session in June 2024. The RPT has been the traditional detection method for pyrogens, the European Directorate for the Quality Of Medicines (EDQM) explained. In June 2021, the European Pharmacopoeia Commission (EPC) committed to completely replace the RPT in the 59 Ph.
STAT
JULY 17, 2024
A clutch of headlines last week suggested the U.S. Senate had achieved a breakthrough in the battle to prevent pharmaceutical companies from abusing the patent system, an issue that has been blamed for boosting prescription drug costs for Americans. But while the Senate bill clearly represents a step forward, the impact will not be nearly as great as originally intended by lawmakers due to industry lobbying.
Pharmacy Times
JULY 17, 2024
Currently, limited data show the effect of adverse drug events in the outpatient setting.
STAT
JULY 17, 2024
LONDON — A Novartis executive on Thursday said “it’s too early to say” whether the company would still submit an experimental myelofibrosis drug for regulatory approval this year, amid questions about the medicine’s data profile and whether it’s sufficient for filing. Novartis had previously said it planned to submit a marketing application for a rare bone marrow cancer drug called pelabresib to the Food and Drug Administration this year.
Fierce Pharma
JULY 17, 2024
Sanofi is looking to bulk up its workforce at its global capacity center in Hyderabad, India, with a multi-year investment totaling 400 million euros ($437 million), according to reports. | The drugmaker plans to grow it its workforce at the site to 2,600, making it the largest of Sanofi's four global capacity centers, according to reports.
pharmaphorum
JULY 17, 2024
Vertex Pharma has teamed up with Orum Therapeutics to develop a conditioning regimen, used to prepare patients to receive gene-editing medicines, that it hopes will offer a more tolerable alternative to current chemotherapy options.Vertex is paying $15 million upfront to get the ball rolling on the collaboration, which could be worth up to $945 million if it exercises options to use the technology for three developmental programmes and all of them hit various milestones.
STAT
JULY 17, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.
Pharmaceutical Technology
JULY 17, 2024
In January, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act.
Med Ed 101
JULY 17, 2024
Allergic rhinitis is a very common condition. I’ve encountered numerous patients throughout my career who take more than one medication to help keep their symptoms at bay. When reviewing polypharmacy cases, I do consider allergy medications as deprescribing targets because oftentimes allergy medications are added and the original success of the first agent is not […] The post Allergy Medications As Deprescribing Targets appeared first on Med Ed 101.
Fierce Pharma
JULY 17, 2024
As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations. | As myriad pharma industry attempts to challenge the Inflation Reduction Act (IRA) fall flat, Johnson & Johnson is settling into a reality of pricing rebates and Medicare drug cost negotiations.
pharmaphorum
JULY 17, 2024
Discover how artificial intelligence is revolutionising drug development and compliance in the pharmaceutical industry with these four impactful ways.
Fierce Healthcare
JULY 17, 2024
Four more community health centers are implementing Suki AI’s ambient scribe in their clinics, the company announced on Thursday. | Suki AI, an ambient scribe solution, says community health centers are able to afford Suki, unlike other AI solutions on the market. Stakeholders have wondered if the healthcare AI revolution will benefit small practices.
Let's personalize your content